A six-microRNA set as prognostic indicators for bile duct cancer.
暂无分享,去创建一个
Chuan Li | T. Wen | Ming Wang | Tian-Fu Wen | Lin-Hai He | Wen-Jiang Zhu | Narasimha Murthy Trishul | Chuan Li | Ming Wang | Wen-Jiang Zhu | Linye He
[1] Le Yu,et al. The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. , 2009, Journal of hepatology.
[2] Tushar Patel,et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. , 2006, Gastroenterology.
[3] H. Swerdlow,et al. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers , 2012, BMC Genomics.
[4] Yanchun Deng,et al. MiR‐483–5p suppresses the proliferation of glioma cells via directly targeting ERK1 , 2012, FEBS letters.
[5] Anindya Dutta,et al. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. , 2007, Genes & development.
[6] A. Kulkarni,et al. Current research in perineural invasion of cholangiocarcinoma , 2010, Journal of experimental & clinical cancer research : CR.
[7] H. Thomas,et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update , 2012, Gut.
[8] Andrey Golubov,et al. Alterations of microRNAs and their targets are associated with acquired resistance of MCF‐7 breast cancer cells to cisplatin , 2010, International journal of cancer.
[9] S. DeMorrow,et al. Genetic and epigenetic changes associated with cholangiocarcinoma: from DNA methylation to microRNAs. , 2007, World journal of gastroenterology.
[10] S. Thorgeirsson,et al. Genetic profiling of intrahepatic cholangiocarcinoma , 2012, Current opinion in gastroenterology.
[11] Brad T. Sherman,et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.
[12] Chi-Ying F. Huang,et al. miRTarBase: a database curates experimentally validated microRNA–target interactions , 2010, Nucleic Acids Res..
[13] C. Burge,et al. Prediction of Mammalian MicroRNA Targets , 2003, Cell.
[14] Mahlon D. Johnson,et al. Increased STAT-3 and synchronous activation of Raf-1-MEK-1-MAPK, and phosphatidylinositol 3-Kinase-Akt-mTOR pathways in atypical and anaplastic meningiomas , 2008, Journal of Neuro-Oncology.
[15] T. Patel,et al. The MicroRNA let-7a Modulates Interleukin-6-dependent STAT-3 Survival Signaling in Malignant Human Cholangiocytes* , 2007, Journal of Biological Chemistry.
[16] J. Marin,et al. MicroRNAs in biliary diseases. , 2012, World journal of gastroenterology.
[17] Levi Garraway,et al. High‐throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide‐3‐kinase and other oncogenes , 2012, Cancer.
[18] Anthony J Gill,et al. miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer , 2009, Clinical Cancer Research.
[19] William C Reinhold,et al. MicroRNAs modulate the chemosensitivity of tumor cells , 2008, Molecular Cancer Therapeutics.
[20] C. Corless,et al. Protein kinase A RII-like (R2D2) proteins exhibit differential localization and AKAP interaction. , 2008, Cell motility and the cytoskeleton.
[21] L. Mazzucchelli. Protein S100A4: too long overlooked by pathologists? , 2002, The American journal of pathology.
[22] Jaakko Astola,et al. Comparison of Affymetrix data normalization methods using 6,926 experiments across five array generations , 2009, BMC Bioinformatics.
[23] T. Okanoue,et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues , 2006, Oncogene.
[24] Shuomin Zhu,et al. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis , 2008, Cell Research.
[25] G. Gores,et al. mir-29 regulates Mcl-1 protein expression and apoptosis , 2007, Oncogene.
[26] V. Ambros,et al. MicroRNA Pathways in Flies and Worms Growth, Death, Fat, Stress, and Timing , 2003, Cell.
[27] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[28] J M Bland,et al. Statistical methods for assessing agreement between two methods of clinical measurement , 1986 .
[29] H. El‐Serag,et al. The epidemiology of cholangiocarcinoma. , 2004, Seminars in liver disease.
[30] G. Gores,et al. MicroRNA‐21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3 , 2009, Hepatology.
[31] I. Ng,et al. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. , 2011, Gastroenterology.
[32] Chuan-hai Zhang,et al. MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[33] D. Bartel,et al. MicroRNA-Directed Cleavage of HOXB8 mRNA , 2004, Science.
[34] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[35] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.